FDA
-
-
-
-
-
-
-
Novus Therapeutics (NVUS) Receives FDA Guidance on OP0201 Phase 2a Study in Patients with Chronic Otitis Media with Effusion
-
-
-
-
-
-
-
Novus Therapeutics (NVUS) Receives FDA Guidance at Type C Meeting for OP-02 in Otitis Media
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

